Tineа Corporis with Trichophyton Rubrum Mimicking a Flare-Up of Psoriasis UnderTreatment with IL17-Inhibitor Ixekizumab

Biologics, as IL17 inhibitors, are frequently prescribed for moderate to severe plaque psoriasis. Although mucocutaneous candida infections are a well-known side effect of IL-17 inhibitors, there is no data about dermatophyte infection under this therapy. Generalized tinea corporis can mimic the cli...

Descripción completa

Detalles Bibliográficos
Autores principales: Emelianov, Vladimir, Feldmeyer, Laurence, Yawalkar, Nikhil, Heidemeyer, Kristine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2021
Materias:
Single Case
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299392/
https://www.ncbi.nlm.nih.gov/pubmed/34326729
http://dx.doi.org/10.1159/000515702
_version_ 1783726261011480576
author Emelianov, Vladimir
Feldmeyer, Laurence
Yawalkar, Nikhil
Heidemeyer, Kristine
author_facet Emelianov, Vladimir
Feldmeyer, Laurence
Yawalkar, Nikhil
Heidemeyer, Kristine
author_sort Emelianov, Vladimir
collection PubMed
description Biologics, as IL17 inhibitors, are frequently prescribed for moderate to severe plaque psoriasis. Although mucocutaneous candida infections are a well-known side effect of IL-17 inhibitors, there is no data about dermatophyte infection under this therapy. Generalized tinea corporis can mimic the clinical picture of psoriasis, especially if concomitant treatment with topical corticosteroids is used. Therefore, physician should be aware of this differential diagnosis if they suspect a loss of efficacy of IL-17-inhibitors with a flare-up of psoriasis.
format Online
Article
Text
id pubmed-8299392
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-82993922021-07-28 Tineа Corporis with Trichophyton Rubrum Mimicking a Flare-Up of Psoriasis UnderTreatment with IL17-Inhibitor Ixekizumab Emelianov, Vladimir Feldmeyer, Laurence Yawalkar, Nikhil Heidemeyer, Kristine Case Rep Dermatol Single Case Biologics, as IL17 inhibitors, are frequently prescribed for moderate to severe plaque psoriasis. Although mucocutaneous candida infections are a well-known side effect of IL-17 inhibitors, there is no data about dermatophyte infection under this therapy. Generalized tinea corporis can mimic the clinical picture of psoriasis, especially if concomitant treatment with topical corticosteroids is used. Therefore, physician should be aware of this differential diagnosis if they suspect a loss of efficacy of IL-17-inhibitors with a flare-up of psoriasis. S. Karger AG 2021-07-09 /pmc/articles/PMC8299392/ /pubmed/34326729 http://dx.doi.org/10.1159/000515702 Text en Copyright © 2021 by S. Karger AG, Basel https://creativecommons.org/licenses/by-nc/4.0/This article is licensed under the Creative Commons Attribution-NonCommercial-4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission.
spellingShingle Single Case
Emelianov, Vladimir
Feldmeyer, Laurence
Yawalkar, Nikhil
Heidemeyer, Kristine
Tineа Corporis with Trichophyton Rubrum Mimicking a Flare-Up of Psoriasis UnderTreatment with IL17-Inhibitor Ixekizumab
title Tineа Corporis with Trichophyton Rubrum Mimicking a Flare-Up of Psoriasis UnderTreatment with IL17-Inhibitor Ixekizumab
title_full Tineа Corporis with Trichophyton Rubrum Mimicking a Flare-Up of Psoriasis UnderTreatment with IL17-Inhibitor Ixekizumab
title_fullStr Tineа Corporis with Trichophyton Rubrum Mimicking a Flare-Up of Psoriasis UnderTreatment with IL17-Inhibitor Ixekizumab
title_full_unstemmed Tineа Corporis with Trichophyton Rubrum Mimicking a Flare-Up of Psoriasis UnderTreatment with IL17-Inhibitor Ixekizumab
title_short Tineа Corporis with Trichophyton Rubrum Mimicking a Flare-Up of Psoriasis UnderTreatment with IL17-Inhibitor Ixekizumab
title_sort tineа corporis with trichophyton rubrum mimicking a flare-up of psoriasis undertreatment with il17-inhibitor ixekizumab
topic Single Case
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299392/
https://www.ncbi.nlm.nih.gov/pubmed/34326729
http://dx.doi.org/10.1159/000515702
work_keys_str_mv AT emelianovvladimir tineacorporiswithtrichophytonrubrummimickingaflareupofpsoriasisundertreatmentwithil17inhibitorixekizumab
AT feldmeyerlaurence tineacorporiswithtrichophytonrubrummimickingaflareupofpsoriasisundertreatmentwithil17inhibitorixekizumab
AT yawalkarnikhil tineacorporiswithtrichophytonrubrummimickingaflareupofpsoriasisundertreatmentwithil17inhibitorixekizumab
AT heidemeyerkristine tineacorporiswithtrichophytonrubrummimickingaflareupofpsoriasisundertreatmentwithil17inhibitorixekizumab

Ejemplares similares